EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS

In this study the results of the investigation of complex treatment with Infliximab and Methotrexate efficacy and safety of 28 patientscomparing with Methotrexate treatment of 41 patients with polyarticular juvenile idiopathic arthritis at the age of 8–17 years are analyzed. The follow-up period was...

Full description

Bibliographic Details
Main Authors: V. A. Kel'tsev, L. I. Grebenkina, S. A. Pyrkova, N. S. Pryanichnikova, S. A. Goryunov, N. V. Lagoda
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2012-03-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/123
_version_ 1797696882621808640
author V. A. Kel'tsev
L. I. Grebenkina
S. A. Pyrkova
N. S. Pryanichnikova
S. A. Goryunov
N. V. Lagoda
author_facet V. A. Kel'tsev
L. I. Grebenkina
S. A. Pyrkova
N. S. Pryanichnikova
S. A. Goryunov
N. V. Lagoda
author_sort V. A. Kel'tsev
collection DOAJ
description In this study the results of the investigation of complex treatment with Infliximab and Methotrexate efficacy and safety of 28 patientscomparing with Methotrexate treatment of 41 patients with polyarticular juvenile idiopathic arthritis at the age of 8–17 years are analyzed. The follow-up period was 1 year. Infliximab was administered according to the following scheme: 0, 2, 6 weeks and then every 8 weeks. The dosage of Infliximab in children with early onset of juvenile idiopathic arthritis was 3,0 mg/kg per infusion. Clinical remission, decrease and normalization of laboratory markers, complete restoration of joints function and improvement of life quality in 57,7% were established after 46 weeks of treatment with Infliximab and Methotrexate comparing with 16% in children treated with Methotrexate monotherapy.
first_indexed 2024-03-12T03:32:32Z
format Article
id doaj.art-2bae079388484bd6ba126633fa3d15f4
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T03:32:32Z
publishDate 2012-03-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-2bae079388484bd6ba126633fa3d15f42023-09-03T13:24:25Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352012-03-01112828910.15690/vsp.v11i2.216123EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITISV. A. Kel'tsev0L. I. Grebenkina1S. A. Pyrkova2N. S. Pryanichnikova3S. A. Goryunov4N. V. Lagoda5Самарский государственный медицинский университетСамарский государственный медицинский университетСамарский государственный медицинский университетСамарский государственный медицинский университетСамарский государственный медицинский университетСамарский государственный медицинский университетIn this study the results of the investigation of complex treatment with Infliximab and Methotrexate efficacy and safety of 28 patientscomparing with Methotrexate treatment of 41 patients with polyarticular juvenile idiopathic arthritis at the age of 8–17 years are analyzed. The follow-up period was 1 year. Infliximab was administered according to the following scheme: 0, 2, 6 weeks and then every 8 weeks. The dosage of Infliximab in children with early onset of juvenile idiopathic arthritis was 3,0 mg/kg per infusion. Clinical remission, decrease and normalization of laboratory markers, complete restoration of joints function and improvement of life quality in 57,7% were established after 46 weeks of treatment with Infliximab and Methotrexate comparing with 16% in children treated with Methotrexate monotherapy.https://vsp.spr-journal.ru/jour/article/view/123дети, ювенильный идиопатический артритлечениеинфликсимабметотрексат
spellingShingle V. A. Kel'tsev
L. I. Grebenkina
S. A. Pyrkova
N. S. Pryanichnikova
S. A. Goryunov
N. V. Lagoda
EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
Вопросы современной педиатрии
дети, ювенильный идиопатический артрит
лечение
инфликсимаб
метотрексат
title EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
title_full EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
title_fullStr EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
title_full_unstemmed EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
title_short EVALUATION OF EFFICACY AND SAFETY OF COMPLEX TREATMENT WITH INFLIXIMAB AND METHOTREXATE COMPARING WITH METHOTREXATE MONOTHERAPY OF CHILDREN WITH JUVENILE POLYARTICULAR IDIOPATHIC ARTHRITIS
title_sort evaluation of efficacy and safety of complex treatment with infliximab and methotrexate comparing with methotrexate monotherapy of children with juvenile polyarticular idiopathic arthritis
topic дети, ювенильный идиопатический артрит
лечение
инфликсимаб
метотрексат
url https://vsp.spr-journal.ru/jour/article/view/123
work_keys_str_mv AT vakeltsev evaluationofefficacyandsafetyofcomplextreatmentwithinfliximabandmethotrexatecomparingwithmethotrexatemonotherapyofchildrenwithjuvenilepolyarticularidiopathicarthritis
AT ligrebenkina evaluationofefficacyandsafetyofcomplextreatmentwithinfliximabandmethotrexatecomparingwithmethotrexatemonotherapyofchildrenwithjuvenilepolyarticularidiopathicarthritis
AT sapyrkova evaluationofefficacyandsafetyofcomplextreatmentwithinfliximabandmethotrexatecomparingwithmethotrexatemonotherapyofchildrenwithjuvenilepolyarticularidiopathicarthritis
AT nspryanichnikova evaluationofefficacyandsafetyofcomplextreatmentwithinfliximabandmethotrexatecomparingwithmethotrexatemonotherapyofchildrenwithjuvenilepolyarticularidiopathicarthritis
AT sagoryunov evaluationofefficacyandsafetyofcomplextreatmentwithinfliximabandmethotrexatecomparingwithmethotrexatemonotherapyofchildrenwithjuvenilepolyarticularidiopathicarthritis
AT nvlagoda evaluationofefficacyandsafetyofcomplextreatmentwithinfliximabandmethotrexatecomparingwithmethotrexatemonotherapyofchildrenwithjuvenilepolyarticularidiopathicarthritis